Another drug shows preliminary signs of efficacy in treating patients with KRAS-mutated cancer, and a study indicates that minority cancer patients struggle to find doctors who share or understand their culture.

by Kate Yandell

A physician writes about her experiences treating patients with CAR-T cell therapy, and the U.S. Food and Drug Administration expands approval of an ovarian cancer drug based on a new biomarker.

by Kate Yandell

A chemotherapy drug used to treat childhood cancer is in short supply, and organizations update exercise recommendations for people who have been diagnosed with cancer.

by Kate Yandell

A researcher with melanoma writes about his experiences trying to modify his gut microbiome, and an article discusses what it means to call a cancer treatment “well tolerated.”

by Kate Yandell

More than half of patients with advanced melanoma who took an immunotherapy combination were alive five years later, and a targeted therapy appears to cause high blood pressure.

by Kate Yandell

A study examines how poor and minority patients are more likely to be diagnosed with cancer in the emergency room, and a cancer survivor considers the lasting effects of chemotherapy.

by Bradley Jones

Article describes efforts to support cancer survivors, radiation meeting focuses on treatment de-escalation, and studies show that brain tumor cells have their own neural network.

by Marci A. Landsmann

Some cancer drugs being tested in clinical trials do not work the way researchers thought they did, and ringing a bell following radiation therapy may increase distress for patients.

by Kate Yandell

Organizations release guidelines on reducing breast cancer risk using medications, and a palliative care doctor discusses the pros and cons of dying at home.

by Kate Yandell

A study looks at hormone therapy and breast cancer risk, and researchers take a closer look at marijuana use in young cancer patients.

by Marci A. Landsmann